Michael Harry Barnett

49PUBLICATIONS
139CO-AUTHORS
Neurology and neuromuscular diseasesMolecular targetsGene and molecular therapyMedical infection agents (incl. prions)Nanotoxicology, health and safety
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (49)

|Jul 13, 2026
Long-Term Ravulizumab Efficacy and Safety in AQP4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder: Final CHAMPION-NMOSD Results.

|Jul 01, 2026
Impact of multiple sclerosis disease-modifying therapies on chronic lesion tissue expansion.

|Dec 26, 2025
Study protocol for a multicentre, randomised, double-blinded, placebo-controlled, multi-arm, multi-stage, trial of SpironolacTone and famciclOovir in the treatment of Progressive Multiple Sclerosis to prevent disability progression: the STOP-MS trial.

Kayla Ward, Vivien Li, Sudarshini Ramanathan

|Sep 29, 2025
The presence of a paramagnetic phase rim in multiple sclerosis is linked to lesion age: An exploratory study.

Samuel Klistorner, Tatiana Usnich, Margareta A Clarke

|Sep 02, 2025
Unilateral focused ultrasound thalamotomy for tremor-dominant Parkinson's disease: blinded evaluation and imaging correlation.

James Peters, Joel Maamary, Kain Kyle

|Aug 04, 2025
Haematopoietic stem cell transplant versus immune-reconstitution therapy in relapsing multiple sclerosis.

Tomas Kalincik, Sifat Sharmin, Izanne Roos

Pageof 9

Frequent Collaborators

18 joint publications

Tomas Kalincik

16 joint publications

Anneke Van der Walt

6 joint publications

Jeannette Lechner-Scott

6 joint publications

Simon Broadley